Foresters Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Foresters Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$4.01M	Sell	23,650 -9,050	-28%	-$1.6M	0.08%	272
2019 Q2	$6M	Buy	32,700 +6,350	+24%	+$1.11M	0.11%	251
2019 Q1	$4.85M	Hold	26,350	–	–	0.08%	286
2018 Q4	$4.37M	Buy	26,350 +8,650	+49%	+$1.5M	0.08%	280
2018 Q3	$3.41M	Buy	+17,700	New	+$3.15M	0.05%	328

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Foresters Investment Management's VRTX Position: Q3 2019 in Review

Foresters Investment Management reduced its Vertex Pharmaceuticals (VRTX) stake by 28% in Q3 2019, selling an estimated $1.6M and leaving 23,650 shares worth $4.01M. The position accounts for 0.08% of the portfolio, ranked #272.

Foresters Investment Management first reported a position in VRTX in Q3 2018 and has held it in 5 quarters since. The position peaked at $6M in Q2 2019. 708 funds tracked by Wall St. Rank hold VRTX as of Q3 2019.

Foresters Investment Management held 23,650 shares of Vertex Pharmaceuticals worth $4.01M as of Q3 2019.
Foresters Investment Management sold 9,050 Vertex Pharmaceuticals shares in Q3 2019, an estimated $1.6M.
Vertex Pharmaceuticals made up 0.08% of Foresters Investment Management's portfolio in Q3 2019, its #272 holding.
Foresters Investment Management first reported a position in Vertex Pharmaceuticals in Q3 2018 and has held it in 5 quarters since.
Foresters Investment Management's Vertex Pharmaceuticals position peaked at $6M in Q2 2019.
708 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2019.

Based on Foresters Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.